法国2006至2015年399例组织学确诊的新诊断脑膜孤立性纤维性肿瘤和血管外皮细胞瘤的描述性流行病学
基于法国脑肿瘤数据库的全国性人群研究纳入2006至2015年46个神经外科中心收治的399例组织学确诊的脑膜孤立性纤维性肿瘤(SFT)/血管外皮细胞瘤(HPC)患者,描述其流行病学特征并评估发病率。SFT/HPC发病率为0.062/10万人年(95%CI 0.056-0.068),与脑膜瘤手术例数比为0.013,男女分布相近,平均手术年龄53.9岁(SD±15.8),组织学行为越具侵袭性则再次手术比例越高。
要点
- SFT/HPC发病率为0.062/10万人年(95%CI 0.056-0.068),与同期手术脑膜瘤之比为0.013。
- SFT占35.8%,HPC占64.2%;女性55.9% vs 男性44.1%;平均手术年龄53.9岁(SD±15.8)。
- 良性SFT/HPC再次手术比例为6.7%,不确定行为为16.6%,恶性为28.4%。
核心结论
- 脑膜SFT和HPC是罕见的CNS间叶性肿瘤,两者具有共同的流行病学特征,支持将其合并为同一实体。
- SFT/HPC发病率低于每年每10亿人中1例,约每100例类似脑膜瘤的切除肿瘤中可诊断1例SFT/HPC。
- SFT/HPC在男女中分布相近,主要诊断年龄在50-55岁左右,肿瘤侵袭性越强,复发概率越高。
研究设计与样本
- 研究处理法国脑肿瘤数据库(FBTDB),开展2006至2015年全国性人群为基础的、所有组织病理学确诊SFT/HPC的研究。
- 研究纳入2006至2015年在法国46个参与神经外科中心之一手术的399例SFT/HPC患者。
主要发现
- SFT/HPC发病率为0.062/10万人年(95%CI 0.056-0.068)。
- SFT占35.8%,HPC占64.2%;同期手术SFT/HPC与脑膜瘤之比为0.013。
- 女性55.9% vs 男性44.1%;全人群平均手术年龄53.9岁(SD±15.8)。
- SFT/HPC手术发病率随年龄增长而增加,在50-55岁年龄组最高。
- 良性SFT/HPC占65.16%,不确定行为占11.53%,恶性占23.31%。
关键数值与推荐
- 良性SFT/HPC患者中6.7%接受第二次手术,不确定行为为16.6%,恶性SFT/HPC为28.4%。
- 切除数量随组织病理学行为更具侵袭性而进展。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Meningeal solitary fibrous tumour (SFT) and haemangiopericytoma (HPC) are uncommon tumours that have been merged into a single entity in the last 2021 WHO Classification of Tumors of the Central Nervous System. To describe the epidemiology of SFT/HPC operated in France and, to assess their incidence. METHODS: We processed the French Brain Tumour Database (FBTDB) to conduct a nationwide population-based study of all histopathologically confirmed SFT/HPC between 2006 and 2015. RESULTS: Our study included 399 SFT/HPC patients, operated in France between 2006 and 2015, in one of the 46 participating neurosurgical centres. The incidence reached 0.062, 95%CI[0.056-0.068] for 100,000 person-years. SFT accounted for 35.8% and, HPC for 64.2%. The ratio of SFT/HPC over meningioma operated during the same period was 0.013. SFT/HPC are about equally distributed in women and men (55.9% vs. 44.1%). For the whole population, mean age at surgery was 53.9 (SD ± 15.8) years. The incidence of SFT/HPC surgery increases with the age and, is maximal for the 50-55 years category. Benign SFT/HPC accounted for 65.16%, SFT/HPC of uncertain behaviour for 11.53% and malignant ones for 23.31%. The number of resection progresses as the histopathological behaviour became more aggressive. 6.7% of the patients with a benign SFT/HPC had a second surgery vs.16.6% in case of uncertain behaviour and, 28.4% for malignant SFT/HPC patients. CONCLUSION: Meningeal SFT and HPC are rare CNS mesenchymal tumours which both share common epidemiological characteristics, asserting their merging under a common entity. SFT/HPC incidence is less that one case for 1 billion per year and, for around 100 meningiomas-like tumours removed, one SFT/HPC may be diagnosed. SFT/HPC are equally distributed in women and men and, are mainly diagnosed around 50-55 years. The more aggressive the tumour, the higher the probability of recurrence.
引用
- Champeaux Depond C, Zouaoui S, Darlix A, et al. Descriptive epidemiology of 399 histologically confirmed newly diagnosed meningeal solitary fibrous tumours and haemangiopericytomas in France: 2006-2015. Acta Neurochir (Wien). 2024. PMID: 39093339. doi:10.1007/s00701-024-06191-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。